Guest Blogs

GUEST POST: Dr. Michele Carbone in Memory of Dr. Baris

By Michele Carbone, MD
This past week-end my friend Professor Izzettin Y Baris died in Turkey.  Dr. Baris, as I called him, was one of the most exceptional individuals I had the privilege to meet. He made a real difference in the life of his patients, and he dedicated his life to improve the conditions of […]


Why do People Contract Mesothelioma?

By Laurie Kazan-Allen
Mesothelioma is an avoidable disease. If governments had first acted when the asbestos hazard was known, the incidence of this deadly cancer would, by now, be much lower. And yet, despite the evidence documenting the deadly consequences of asbestos exposure, governments turned a blind eye to an industrial sector which was generating thousands […]


Meso Foundation Clinical Trial Consortium for Faster Advancement of Mesothelioma Research

by Lee M. Krug, MD
At the International Mesothelioma Interest Group Meeting in Boston, a group of investigators convened at a Clinical Trials Design Workshop to discuss the challenges of conducting trials in this disease. The rarity of mesothelioma poses various issues with regards to proper study design, accrual, and interest by pharmaceutical companies. One theme […]


The End of Canada’s Asbestos Reign of Terror?

by Laurie Kazan-Allen 
Canadian asbestos has poisoned American citizens for over one hundred years.[1] According to the United States Geological Survey from 1900: “The United States was the largest market for exported Canadian (asbestos) fiber.” It is therefore not unreasonable to suggest that the majority of asbestos-related disease in the U.S. was caused by exposure to […]


GUEST POST: An ASCO Update from Dr. Lee M. Krug, MD

The Meso Foundation is happy to present this special guest blogpost from Lee M. Krug, MD, Associate Attending Physician in the Division of Thoracic Oncology, Department of Medicine at Memorial Sloan-Kettering Cancer Center in New York, New York and Director of the Mesothelioma Program at Memorial Sloan-Kettering Cancer Center. Dr. Krug has investigated multimodality approaches […]